Sign In
Buy CI
$280.68
+9.95 (+3.68%)
At Close: Jun 04, 2026
Cigna's Evernorth to Scrap Drug Rebate Model for Upfront Discounts
07:37am, Monday, 27'th Oct 2025
Cigna Group is launching a new rebate-free pharmacy benefit model which aims to bring down drug costs directly at the counter.
Evernorth Announces New Era of Pharmacy Benefit Services to Lower Americans' Medication Costs
06:15am, Monday, 27'th Oct 2025
Unveils Transparent Rebate-Free Pharmacy Benefit; Lower Costs and Better Experience for Americans; Greater Support for Local Pharmacies BLOOMFIELD, Conn. , Oct. 27, 2025 /PRNewswire/ -- Evernorth, the
Cigna will end drug rebates in many private health plans in 2027, Bloomberg News reports
06:11am, Monday, 27'th Oct 2025
Cigna Group will eliminate prescription drug rebates in many of its commercial health plans in 2027, Bloomberg News reported on Monday.
The Cigna Group Declares Quarterly Dividend
04:30pm, Wednesday, 22'nd Oct 2025
BLOOMFIELD, Conn. , Oct. 22, 2025 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.51 per share of its common stock, payable on December 18, 2
The Cigna Group Foundation Teamed Up with Community Organizations To Enhance 34,000 Lives with Youth Mental Health Support
01:45pm, Thursday, 09'th Oct 2025
BLOOMFIELD, Conn. , Oct. 9, 2025 /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), today released its Improving Youth Mental Health 2025 Impact Report, h
Will Cigna (CI) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Thursday, 02'nd Oct 2025
Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Cigna Group's Third Quarter 2025 Earnings Release Details
06:00am, Thursday, 02'nd Oct 2025
BLOOMFIELD, Conn. , Oct. 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its third quarter 2025 financial results on Thursday, October 30, 2025, and will host a c
UnitedHealthcare and Cigna Coverage for Cleerly LABS Advanced Plaque Analysis Begins October 1st
11:02am, Tuesday, 30'th Sep 2025
DENVER--(BUSINESS WIRE)-- #AI--Cleerly, the leader in AI-based advanced cardiovascular imaging, today announced that groundbreaking coverage policies from UnitedHealthcare and Cigna for Cleerly® LABS
Cigna to Support Cleerly's AI Cardiovascular Imaging Solutions
10:20am, Tuesday, 30'th Sep 2025
CI expands coverage to Cleerly's AI cardiovascular imaging, boosting access, early detection and digital healthcare adoption.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:51am, Tuesday, 30'th Sep 2025
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis
09:11am, Monday, 29'th Sep 2025
Heartflow secures FDA clearance and Cigna coverage for its Next Gen Plaque Analysis, boosting accuracy and nationwide access.
Cigna Approves Coverage for Cleerly's AI Cardiovascular Imaging Technology
11:00am, Wednesday, 24'th Sep 2025
DENVER--(BUSINESS WIRE)-- #AI--Cleerly, a leader in AI-based cardiovascular imaging, today announced that Cigna will begin covering Cleerly LABS Advanced Plaque Analysis effective October 1, 2025. The
Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform
04:05pm, Monday, 22'nd Sep 2025
AI-Powered Heartflow Plaque Analysis to be Covered by Cigna Health Plans Nationwide AI-Powered Heartflow Plaque Analysis to be Covered by Cigna Health Plans Nationwide
Cigna: Pounce On This SWAN Bargain Now
07:30am, Monday, 22'nd Sep 2025
Cigna provides a market-beating dividend with plenty of room for further growth. The company topped analysts' expectations for revenue and adjusted EPS in Q2. Cigna's A-rated balance sheet gives it th
2 HMO Stocks Poised to Thrive Despite Escalating Medical Costs
12:06pm, Thursday, 18'th Sep 2025
The Medical-HMO industry benefits from strength in commercial plans, M&A and expected Medicare rate hikes, but rising costs, regulatory shifts and workforce shortages strain margins. CI and HUM are li
